Product Information
VARENICLINE STARTING MONTH BOX is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3972 per EA under NDC 70748012513. Its NADAC has been published 125 times since May 15, 2024.
FDA first approved this application on Dec 4, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the VARENICLINE TARTRATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
70748012513
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA211862FDA Approved
12/4/2023
TE Code
AB
On Market Since
3/20/2024
Price Statistics
The NADAC for VARENICLINE STARTING MONTH BOX has been published 125 times since May 15, 2024, and over the history we have for it it has declined 83.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3972 per EA |
|---|---|
| All-time high | $2.4578 (May 15, 2024) |
| All-time low | $0.3972 (Sep 23, 2026) |
| 52-week high | $0.5229 |
| 52-week low | $0.3972 |
| Median price | $0.5229 |
| Average price | $0.7415 |
| Largest weekly change | +71.9% (Dec 18, 2024) |
| Weeks tracked | 125 |
| Tracking since | May 15, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
VARENICLINE TARTRATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VARENICLINE STARTING MONTH BOX?
The current National Average Drug Acquisition Cost (NADAC) for VARENICLINE STARTING MONTH BOX, manufactured by Lupin Pharmaceuticals Inc., is $0.3972 per EA (NDC 70748012513), effective Sep 30, 2026.
How has the price of VARENICLINE STARTING MONTH BOX changed over time?
Over the history we have for it, the NADAC for VARENICLINE STARTING MONTH BOX has declined 83.8%. It has been tracked across 125 weekly CMS publications since May 15, 2024.
What are the highest and lowest recorded NADAC prices for VARENICLINE STARTING MONTH BOX?
Since May 15, 2024, the NADAC for VARENICLINE STARTING MONTH BOX has ranged from a low of $0.3972 (Sep 23, 2026) to a high of $2.4578 (May 15, 2024), with a median of $0.5229 per EA.
Are there cheaper alternatives to VARENICLINE STARTING MONTH BOX?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VARENICLINE STARTING MONTH BOX in a comparable dosage form, but none are currently priced below it.
Who manufactures VARENICLINE STARTING MONTH BOX?
VARENICLINE STARTING MONTH BOX (NDC 70748012513) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.